Workshop B Predicting the Patients of Tomorrow with Earlier Diagnosis Across Pulmonary Fibrosis for Improved Clinical Outcomes
Time: 9:00 am
day: Pre-Conference Workshop B
Details:
• What benefits do earlier intervention at the ILA and ILD stage
before progressive fibrosis present for improved treatment
outcomes
• Uncovering predictive biomarkers to determine a risk score
of acquiring a progressive phenotype for individual treatment
strategies
• Exploring the key factors driving progression at different
stages to design effective clinical trials
• Highlighting the role of HRCT and PET scans to visualize and
monitor early-stage fibrosis in both IPF and ILDs